6-K - IMRN - Equibles

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the Month of November 2025

Commission File Number: 001-38104

IMMURON LIMITED

(Name of Registrant)

Level 3, 62 Lygon Street, Carlton South,Victoria, 3053, Australia

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐ No ☒

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-

IMMURON LIMITED

EXPLANATORY NOTE

Immuron Limited (the “Company”) published two announcements (the “Public Notices”) to the Australian Securities Exchange on November 6, 2025 titled:

-	Proposed issue of securities - IMC
-

A copy of the Public Notice is attached as an exhibit to this report on Form 6-K.

This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

EXHIBITS

Exhibit <br><br>Number	Description
99.1	Proposed issue of securities - IMC

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	IMMURON LIMITED
Date: November 6, 2025	By:	/s/ Phillip Hains
		Phillip Hains
		Company Secretary

Exhibit99.1

Appendix<br> 3B - Proposed issue of securities

Announcement Summary

Entity name

IMMURON LIMITED

Announcement Type

New announcement

Date of this announcement

6/11/2025

The Proposed issue is:

A placement or other type of issue

Total number of +securities proposed to be issued for a placement or other type of issue

ASX<br> +security code	+Security<br> description	Maximum<br> Number of<br><br>+securities<br> to be issued
IMC	ORDINARY<br> FULLY PAID	8,495,080

Proposed +issue date

7/11/2025

Refer to next page for full details of the announcement

Appendix 3B - Proposed issue of securities	1 / 5
Appendix<br> 3B - Proposed issue of securities
---

Part 1 - Entity and announcement details

1.1Name of +Entity

IMMURON LIMITED

We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules.

If the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also apply for quotation of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final number of +securities issued under the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete and lodge with ASX an Appendix 2A online form notifying ASX of their issue and applying for their quotation).

1.2 Registered Number Type<br><br> <br><br><br> <br>ABN	Registration Number<br><br> <br><br><br> <br>80063114045

1.3ASX issuer code

IMC

1.4The announcement is

New announcement

1.5Date of this announcement

6/11/2025

1.6The Proposed issue is:

A placement or other type of issue

Appendix 3B - Proposed issue of securities	2 / 5
Appendix<br> 3B - Proposed issue of securities
---

Part 7 - Details of proposed placement or other issue

Part 7A - Conditions

7A.1 Do any external approvals need to be obtained or other conditions satisfied before the placement or other type of issue can proceed on an unconditional basis?

Part 7B - Issue details

Is<br> the proposed security a ‘New class’ (+securities in a class that is not yet quoted<br> or recorded by ASX) or an ‘Existing class’ (additional securities in a class<br> that is already quoted or recorded by ASX)?<br><br> <br><br><br> <br>Existing<br> class	Will<br> the proposed issue of this<br><br> <br>+security<br> include an offer of attaching +securities?<br><br> <br><br><br> <br>No

Details of +securities proposed to be issued

ASX +security code and description

IMC : ORDINARY FULLY PAID

Number of +securities proposed to be issued

8,495,080

Offer price details

Are the +securities proposed to be issued being issued for a cash consideration?

Yes

In what currency is the cash consideration being paid?<br><br> <br><br><br> <br>AUD<br> - Australian Dollar	What is the issue price per +security?<br><br> <br><br><br> <br>AUD<br> 0.07560

Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class?

Yes

Appendix 3B - Proposed issue of securities	3 / 5
Appendix<br> 3B - Proposed issue of securities
---

Part 7C - Timetable

7C.1 Proposed +issue date

7/11/2025

Part 7D - Listing Rule requirements

7D.1 Has the entity obtained, or is it obtaining, +security holder approval for the entire issue under listing rule 7.1?

7D.1b Are any of the +securities proposed to be issued without +security holder approval using the entity’s 15% placement capacity under listing rule 7.1?

Yes

7D.1b ( i ) How many +securities are proposed to be issued without security holder approval using the entity’s 15% placement capacity under listing rule 7.1?

8,495,080<br> Fully Paid Ordinary Shares

7D.1c Are any of the +securities proposed to be issued without +security holder approval using the entity’s additional 10% placement capacity under listing rule 7.1A (if applicable)?

7D.2 Is a party referred to in listing rule 10.11 participating in the proposed issue?

7D.3 Will any of the +securities to be issued be +restricted securities for the purposes of the listing rules?

7D.4 Will any of the +securities to be issued be subject to +voluntary escrow?

Appendix 3B - Proposed issue of securities	4 / 5
Appendix<br> 3B - Proposed issue of securities
---

Part 7E - Fees and expenses

7E.1 Will there be a lead manager or broker to the proposed issue?

7E.2 Is the proposed issue to be underwritten?

7E.4 Details of any other material fees or costs to be incurred by the entity in connection with the proposed issue

Part 7F - Further Information

7F.01 The purpose(s) for which the entity is issuing the securities

For<br>further research and development activities and provide ongoing working capital.

7F.1 Will the entity be changing its dividend/distribution policy if the proposed issue proceeds?

7F.2 Any other information the entity wishes to provide about the proposed issue

The shares (Nasdaq: IMRN)<br>were purchased by US investors from our US At-The-Market (ATM) facility (managed by H.c. Wainwright & Co.) This is a low fee, no<br>discount facility.

7F.3 Any on-sale of the +securities proposed to be issued within 12 months of their date of issue will comply with the secondary sale provisions in sections 707(3) and 1012C(6) of the Corporations Act by virtue of:

The publication of a cleansing notice under section 708A(5), 708AA(2)(f), 1012DA(5) or 1012DAA(2)(f)

Appendix 3B - Proposed issue of securities	5 / 5